The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
The U.S. government has ordered 300 million doses of a potential COVID-19 virus being developed by AstraZeneca and Oxford University and hopes first doses can be made available by October, the Department of Health and Human Services said on Thursday.
“This contract with AstraZeneca is a major milestone in Operation Warp Speed’s work toward a safe, effective, widely available vaccine by 2021,” HHS Secretary Alex Azar said in a statement.
Related posts:
COVID-19 vaccine: EU seals deal to buy 300 million doses from Pfizer
Covid-19 Delta variant: Akwa Ibom orders one million doses of vaccine
COVID-19: Britain orders additional 35 million vaccine doses from Pfizer-BioNTech
US purchases additional 100 million doses of Pfizer Covid-19 vaccine
Nigeria to receive 42 million doses of Covid-19 Vaccine – Minister
BUA group procures 1 million doses of AstraZeneca Covid-19 Vaccine for Nigerians
US plans to distribute 6.4 million doses of Pfizer vaccine in December
COVID-19: South Africa to import 1.5m doses of AstraZeneca vaccine
